Ana Isabel Aller

850 total citations
19 papers, 447 citations indexed

About

Ana Isabel Aller is a scholar working on Infectious Diseases, Epidemiology and Clinical Biochemistry. According to data from OpenAlex, Ana Isabel Aller has authored 19 papers receiving a total of 447 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 12 papers in Epidemiology and 3 papers in Clinical Biochemistry. Recurrent topics in Ana Isabel Aller's work include Antifungal resistance and susceptibility (12 papers), Fungal Infections and Studies (8 papers) and Nail Diseases and Treatments (7 papers). Ana Isabel Aller is often cited by papers focused on Antifungal resistance and susceptibility (12 papers), Fungal Infections and Studies (8 papers) and Nail Diseases and Treatments (7 papers). Ana Isabel Aller collaborates with scholars based in Spain, United Kingdom and United States. Ana Isabel Aller's co-authors include Estrella Martín‐Mazuelos, M. J. Gutiérrez, Samuel Bernal, Jesús Gómez‐Mateos, Lynn Steele‐Moore, Fernando Lozano, F Recio, William J. Holloway, Ana Espinel-Ingroff and María Ángeles Martínez and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy and Journal of Hospital Infection.

In The Last Decade

Ana Isabel Aller

19 papers receiving 437 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ana Isabel Aller Spain 13 355 327 69 43 35 19 447
Catiana Dudiuk Argentina 13 404 1.1× 306 0.9× 73 1.1× 35 0.8× 36 1.0× 21 444
Luigi Falconi Di Francesco Italy 13 509 1.4× 421 1.3× 48 0.7× 59 1.4× 37 1.1× 15 588
Lucas Xavier Bonfietti Brazil 11 388 1.1× 350 1.1× 76 1.1× 51 1.2× 49 1.4× 28 521
Walter Vivot Argentina 13 384 1.1× 361 1.1× 129 1.9× 43 1.0× 50 1.4× 28 486
Khaled Alobaid Kuwait 13 317 0.9× 283 0.9× 59 0.9× 47 1.1× 19 0.5× 25 382
Alexander V. Veselov Russia 3 326 0.9× 249 0.8× 36 0.5× 38 0.9× 30 0.9× 11 388
Carol B. Bolden United States 7 552 1.6× 467 1.4× 61 0.9× 49 1.1× 39 1.1× 7 591
Shalini Upadhyay India 5 504 1.4× 410 1.3× 47 0.7× 46 1.1× 38 1.1× 17 573
S. B. Killian United States 8 329 0.9× 259 0.8× 91 1.3× 29 0.7× 37 1.1× 9 419
Narges Aslani Iran 12 222 0.6× 190 0.6× 88 1.3× 49 1.1× 56 1.6× 26 376

Countries citing papers authored by Ana Isabel Aller

Since Specialization
Citations

This map shows the geographic impact of Ana Isabel Aller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Isabel Aller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Isabel Aller more than expected).

Fields of papers citing papers by Ana Isabel Aller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Isabel Aller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Isabel Aller. The network helps show where Ana Isabel Aller may publish in the future.

Co-authorship network of co-authors of Ana Isabel Aller

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Isabel Aller. A scholar is included among the top collaborators of Ana Isabel Aller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Isabel Aller. Ana Isabel Aller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Merchante, Nicolás, Rocío Herrero, Pilar González-de-la-Aleja, et al.. (2022). Impact of COVID19 pandemic on the incidence of health-care associated Clostridioides difficile infection. Anaerobe. 75. 102579–102579. 9 indexed citations
2.
Gago, Sara, Ana Alastruey‐Izquierdo, Isabel Cuesta, et al.. (2016). Molecular identification, antifungal resistance and virulence of Cryptococcus neoformans and Cryptococcus deneoformans isolated in Seville, Spain. Mycoses. 60(1). 40–50. 40 indexed citations
3.
Velasco, C., Luis Eduardo López-Cortés, Francisco J. Caballero, et al.. (2012). Clinical and molecular epidemiology of meticillin-resistant Staphylococcus aureus causing bacteraemia in Southern Spain. Journal of Hospital Infection. 81(4). 257–263. 12 indexed citations
4.
5.
Alados, Juan Carlos, et al.. (2009). Diseño de un laboratorio de microbiología clínica. Enfermedades Infecciosas y Microbiología Clínica. 28(7). 453–460. 5 indexed citations
6.
Aller, Ana Isabel, et al.. (2008). Activity of BAL 4815 against filamentous fungi. Journal of Antimicrobial Chemotherapy. 61(5). 1083–1086. 20 indexed citations
7.
Castro, Carmen, José-Carlos Palomares-Salas, Ana Isabel Aller, et al.. (2008). Molecular detection and identification of Aspergillus spp. from clinical samples using real‐time PCR. Mycoses. 52(2). 129–134. 23 indexed citations
8.
9.
Aller, Ana Isabel, et al.. (2006). Evaluation of Disk Diffusion Method for Determining Posaconazole Susceptibility of Filamentous Fungi: Comparison with CLSI Broth Microdilution Method. Antimicrobial Agents and Chemotherapy. 50(3). 1108–1111. 37 indexed citations
10.
Aller, Ana Isabel, et al.. (2003). Colecistitis aguda litiásica asociada a Brucella melitensis. Enfermedades Infecciosas y Microbiología Clínica. 21(8). 464–465. 2 indexed citations
11.
Aller, Ana Isabel, et al.. (2003). Colecistitis aguda litiásica asociada a Brucella melitensis. Enfermedades Infecciosas y Microbiología Clínica. 21(8). 464–465. 1 indexed citations
12.
13.
Aller, Ana Isabel, Estrella Martín‐Mazuelos, Fernando Lozano, et al.. (2000). Correlation of Fluconazole MICs with Clinical Outcome in Cryptococcal Infection. Antimicrobial Agents and Chemotherapy. 44(6). 1544–1548. 127 indexed citations
14.
Aller, Ana Isabel. (2000). Comparison of the Etest and microdilution method for antifungal susceptibility testing of Cryptococcus neoformans to four antifungal agents. Journal of Antimicrobial Chemotherapy. 46(6). 997–1000. 24 indexed citations
15.
Martín‐Mazuelos, Estrella, M. J. Gutiérrez, Ana Isabel Aller, et al.. (1999). A comparative evaluation of Etest and broth microdilution methods for fluconazole and itraconazole susceptibility testing of Candida spp.. Journal of Antimicrobial Chemotherapy. 43(4). 477–481. 21 indexed citations
16.
Martín‐Mazuelos, Estrella, et al.. (1997). Response to fluconazole and itraconazole of Candida spp. in denture stomatitis. Mycoses. 40(7-8). 283–289. 19 indexed citations
17.
Martín‐Mazuelos, Estrella, et al.. (1996). Antifungal Activity of Sertaconazole in vitro against Clinical Isolates of <i>Candida</i> spp.. Chemotherapy. 42(2). 112–117. 14 indexed citations
18.
Bernal, Samuel, et al.. (1996). Evaluation of CHROMagar candida medium for the isolation and presumptive identification of species of candida of clinical importance. Diagnostic Microbiology and Infectious Disease. 24(4). 201–204. 54 indexed citations
19.
Aller, Ana Isabel, et al.. (1995). Antifungal Activity of LY295337 in vitro against Clinical Isolates of <i>Candida </i>spp.. Chemotherapy. 41(4). 276–280. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Catiana Dudiuk Breakdown of academic impact, for papers by Luigi Falconi Di Francesco Breakdown of academic impact, for papers by Lucas Xavier Bonfietti Breakdown of academic impact, for papers by Walter Vivot Breakdown of academic impact, for papers by Khaled Alobaid Breakdown of academic impact, for papers by Alexander V. Veselov Breakdown of academic impact, for papers by Carol B. Bolden Breakdown of academic impact, for papers by Shalini Upadhyay Breakdown of academic impact, for papers by S. B. Killian Breakdown of academic impact, for papers by Narges Aslani
Rankless by CCL
2026